Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced dose tranexamic acid in craniosynostosis surgery
NCT02188576Phase 4Completed
- Sponsor
- Boston Children's Hospital
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in Craniosynostosis (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Efficacy of TXA in Children Having Craniosynostosis Surgery at 24 hours. Started Aug 2014; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Craniosynostosis
Beyond the preview
Go deeper on NCT02188576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188576.